LPL Financial
STOK icon

LPL Financial’s Stoke Therapeutics STOK Stock Holding History

LPL Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$553K Buy
21,264
+619
+3% +$18.7K ﹤0.01% 5031
2026
Q2 		$676K Sell
20,645
-15,402
-43% -$494K ﹤0.01% 4766
2026
Q1 		$1.17M Buy
36,047
+28,667
+388% +$940K ﹤0.01% 4040
2025
Q4 		$234K Buy
+7,380
New +$222K ﹤0.01% 5345
2025
Q3 		– Sell
-12,604
Closed -$143K – 5984
2025
Q2 		$143K Buy
+12,604
New +$120K ﹤0.01% 5183

Other funds holding STOK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

LPL Financial's STOK Position: Q3 2026 in Review

LPL Financial increased its Stoke Therapeutics (STOK) stake by 3% in Q3 2026, buying an estimated $18.7K and bringing the position to 21,264 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #5031.

LPL Financial first reported a position in STOK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.17M in Q1 2026. 120 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • LPL Financial held 21,264 shares of Stoke Therapeutics worth $553K as of Q3 2026.
  • LPL Financial bought 619 Stoke Therapeutics shares in Q3 2026, an estimated $18.7K.
  • Stoke Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5031 holding.
  • LPL Financial first reported a position in Stoke Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • LPL Financial's Stoke Therapeutics position peaked at $1.17M in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.